More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
by CNBC
CNBC— For the first time, some Medicare beneficiaries will be able to access Novo Nordisk's Wegovy without having to shoulder the total monthly price tag.
Tech Times—Oxford Study: COVID-19 Vaccines Dramatically Reduce Disease Severity. A groundbreaking study by scientists at the University of Oxford reveals that COVID-19 vaccines, particularly the ChAdOx1 nCoV-19 vaccine, drastically reduce future disease severity.
Miami Herald—Data breach may have involved millions of patients, Kaiser says. What was leaked?. Kaiser Permanente is notifying 13.4 million patients their data may have been sent to Google, X and other third-party vendors.
WWLP.com—1 in 4 Medicare beneficiaries with obesity could get Wegovy despite coverage ban. Medicare is prohibited from covering weight loss medications due to the Medicare Modernization Act of 2003.